Rule Breaker Portfolio

Amgen Corp.

AMGN Buy Stats

On December 16, 1998, the Rule Breaker portfolio bought 290 shares of rule-breaking, biotech-leading Amgen Corp. (Nasdaq: AMGN). The price paid was $85 3/4 per share before commissions. For the buy report on Amgen which explains the company in detail and why it was bought, please click here.

ACTION:Bought
TICKER:AMGN
PRICE:$85 3/4
COMMISSION:$8
TOTAL COST:$24,875.50